Search Within

Hebert Alberto Vargas Alvarez

  1. "Molecular Imaging and Therapy Service"
  2. "Michael Morris"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (3)
  3. Review (1)
Groups
  1. Department of Medicine (15)
  2. Genitourinary Oncology Service (15)
  3. Molecular Imaging and Therapy Service (15)
  4. Solid Tumor Oncology Division (15)
  5. GSK Faculty (11)
  6. Radiology, Department of (10)

More Groups

People
  1. Michael Morris (15)
  2. Howard Scher (12)
  3. Hedvig Hricak (6)
  4. Steven Larson (6)
  5. Andreas Wibmer (5)
  6. Mithat Gonen (5)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (5)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Nuclear Medicine (4)
  2. Journal of Clinical Oncology (3)
  3. JAMA Oncology (2)
  4. Radiology (2)
  5. Clinical Genitourinary Cancer (1)
  6. European Urology Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Society of Nuclear Medicine (4)
  3. American Medical Association (2)
  4. Radiological Society of North America, Inc. (2)
  5. Elsevier BV (1)
  6. Elsevier Inc. (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Automated analysis of FDG-PET/CT imaging to monitor heterogeneous disease response in metastatic castration-resistant prostate cancer
    Meeting Abstract

    Barnett, E.; Woo, S.; Perk, T. G.; Munian-Govindan, R.; Lokre, O.; Gajar, R. N.; Erazo, T.; Carbone, E.; Morris, M. J.; Vargas, H. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Correlation between imaging-based intermediate endpoints and overall survival in men with metastatic castration-resistant prostate cancer: Analysis of 28 randomized trials using the Prostate Cancer Clinical Trials Working Group (PCWG2) criteria in 16,511 patients
    Journal Article

    Woo, S.; Suh, C. H.; Wibmer, A. G.; Becker, A. S.; Teo, M. Y.; Gönen, M.; Hricak, H.; Scher, H. I.; Morris, M. J.; Vargas, H. A.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Quantification of metastatic prostate cancer whole-body tumor burden with (18)F-FDG PET parameters and associations with overall survival after first-line abiraterone or enzalutamide: A single-center retrospective cohort study
    Journal Article

    Wibmer, A. G.; Morris, M. J.; Gonen, M.; Zheng, J.; Hricak, H.; Larson, S.; Scher, H. I.; Vargas, H. A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Comparison of magnetic resonance imaging-stratified clinical pathways and systematic transrectal ultrasound-guided biopsy pathway for the detection of clinically significant prostate cancer: A systematic review and meta-analysis of randomized controlled trials
    Review

    Woo, S.; Suh, C. H.; Eastham, J. A.; Zelefsky, M. J.; Morris, M. J.; Abida, W.; Scher, H. I.; Sidlow, R.; Becker, A. S.; Wibmer, A. G.; more...
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • Diagnostic performance of (18)F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of (18)F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC)
    Meeting Abstract

    Morris, M. J.; Durack, J. C.; Alva, A. S.; Vargas, H. A.; Piert, M.; Pachynski, R. K.; Pouliot, F.; Beauregard, J. M.; Preston, M. A.; Choudhury, A. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of simplified methods for quantification of (18)F-FDHT uptake in patients with metastatic castration-resistant prostate cancer
    Journal Article

    Kramer, G. M.; Yaqub, M.; Vargas, H. A.; Schuit, R. C.; Windhorst, A. D.; van den Eertwegh, A. J. M.; van der Veldt, A. A. M.; Bergman, A. M.; Burnazi, E. M.; Lewis, J. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Healthy tissue uptake of (68)Ga-prostate-specific membrane antigen, (18)F-DCFPyL, (18)F-fluoromethylcholine, and (18)F-dihydrotestosterone
    Journal Article

    Jansen, B. H. E.; Kramer, G. M.; Cysouw, M. C. F.; Yaqub, M. M.; de Keizer, B.; Lavalaye, J.; Booij, J.; Vargas, H. A.; Morris, M. J.; Vis, A. N.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Journal Article

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Vargas, H. A.; Rathkopf, D.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Reproducibility and repeatability of semiquantitative (18)F-fluorodihydrotestosterone uptake metrics in castration-resistant prostate cancer metastases: A prospective multicenter study
    Journal Article

    Vargas, H. A.; Kramer, G. M.; Scott, A. M.; Weickhardt, A.; Meier, A. A.; Parada, N.; Beattie, B. J.; Humm, J. L.; Staton, K. D.; Zanzonico, P. B.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer
    Journal Article

    Fox, J. J.; Gavane, S. C.; Blanc-Autran, E.; Nehmeh, S.; Gonen, M.; Beattie, B.; Vargas, H. A.; Schoder, H.; Humm, J. L.; Fine, S. W.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save